International Journal of Antimicrobial Agents
Publisher: Elsevier · ISSN 0924-8579 · 84 articles
- The pitfalls of HIV-1 DNA resistance genotyping: What it can and cannot tell us
- Antibacterial dose optimisation in patients with febrile neutropenia: Are we targeting the right patients and the right endpoints?
- Remodelling the host immune microenvironment in carbapenem-resistant Klebsiella pneumoniae: An evidence-graded framework for host-directed intervention
- AI strategies to combat antimicrobial resistance
- Pharmacokinetic and pharmacokinetic/pharmacodynamic (PK/PD) considerations of ceftaroline and ceftobiprole for the treatment of Staphylococcus aureus infections: A systematic review
- Antibiotic resistance in Helicobacter pylori: pathogenic mechanisms and eradication barriers
- Clinical pharmacology and therapeutic considerations of isavuconazole in special populations: A narrative review
- Nipah virus: An exceptionally virulent emerging zoonotic pathogen
- Examining the global antimicrobial resistance surveillance landscape in food-producing animals
- Convergence of carbapenem resistance and hypervirulence in Klebsiella pneumoniae in Europe: A systematic review
- Advancing bacteriophage therapy through encapsulation: An evidence-based scoping review from animal trials
- Disc diffusion and ETEST (gradient diffusion) may produce false susceptible results for Pseudomonas aeruginosa from cystic fibrosis patients due to inducible colistin tolerance
- Biomedical applications of antimicrobial peptides: Multifunctional mechanisms, engineering strategies, and therapeutic development
- Proteomics reveals the mechanism by which sodium oleate decreases Escherichia coli susceptibility to gentamicin
- Real-world use of liposomal amphotericin B: A large retrospective, observational, multicentre study
- Global burden of bacterial antimicrobial resistance among children under 5 years 1990−2021: A systematic analysis with forecasts to 2050
- Evaluation of vancomycin bolus/standard and continuous infusion on nephrotoxicity in a rat model
- Prevalence of third-generation cephalosporin-resistant Salmonella in animals in China: The key role of ESBL, AmpC, and other β-lactamase strains in the genome
- Real-world safety signals of fluoroquinolone-associated peripheral neuropathy: Analysis of US and Canadian databases combined with mechanistic exploration
- Appropriate therapy and survival in carbapenem-resistant Enterobacterales bacteraemia: A multicentre cohort study on epidemiology and risk factors
- Ecological antagonism constrains receptor-diverse phage cocktail efficacy against multidrug-resistant Enterobacter hormaechei
- Genomic epidemiology and resistance determinants of Pseudomonas aeruginosa in bronchiectasis across China: A multicentre study
- Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: A pharmacovigilance study and Global Burden of Disease Study 2023
- Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024)
- Vancomycin population pharmacokinetics and optimized dosing in critically ill infants and children
- Pulmonary penetration of intravenous rifabutin in healthy participants: A multiple-dose pharmacokinetic study
- A clinical prediction model to support risk-adapted fibrinogen monitoring during tigecycline therapy: Multicentre development and validation
- A randomised controlled trial evaluating a novel individualised treatment strategy for carbapenem-resistant Gram-negative bacterial infections
- Virologic response to bictegravir/emtricitabine/tenofovir alafenamide in people with advanced HIV-1 disease: A propensity-weighted multicentre cohort study
- Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-centre, open-label study